Company overview
Basic information
Company name
LIETUVOS ONKOLOGŲ DRAUGIJA
Company code
191933010
Registered address
Vilnius, Santariškių g. 1, LT-08406
Registration date
1996-11-08
Company age: 29 y. 11 mo.
Contact information
Edit data
Phone
Presented as an image – cannot be copied
Presented as an image – cannot be copied
Email
Presented as an image – cannot be copied
Presented as an image – cannot be copied
Website
https://www.nvi.lt
Indicators
Risk factors
Activity
Legal form
Association
NACE activity
Activities of professional membership organisations
Sector
Namų ūkiams paslaugas teikiančios ne pelno institucijos
Ownership form
Private without foreign capital
Beneficiary of support
Yes, since 2004-06-07
NVO
Non-governmental organization since 2025-04-01
LIETUVOS ONKOLOGŲ DRAUGIJA
Company code: 191933010
Address: Vilnius, Santariškių g. 1, LT-08406
Description
This description was generated by artificial intelligence.
LIETUVOS ONKOLOGU DRAUGIJA (company code 191933010) is an operational association registered in 1996 and based in Vilnius, Santariškiu g. 1, Vilniaus m. sav., Vilniaus apskr. It is classified as a public entity in the sector of non-profit institutions providing services to households, with a governance model described as CEO with board/council. The company is recorded as privately owned, with Lithuanian natural and legal persons holding more than 50% of the authorised capital and no foreign investor capital. Its main activity is coded EVRK T.94.12.00, Activities of professional membership organisations. Financially, the association reported revenue of €33.5K in 2025, following €55.6K in 2024 and €33.1K in 2023. Revenue declined by 39.8% year on year in 2025, while the two-year change remained slightly positive at 1.1%. Equity stayed at €7.8K across the reported years, liabilities were €168 in 2025, and total assets were €23.8K. The company is classified as micro in size.
Download a detailed company report
Make confident decisions with all the information about LIETUVOS ONKOLOGŲ DRAUGIJA. In one document, you will find full financial data, risk and potential assessment, and key Scoris insights.